Cereius
Latest round
- Series A
Last raised
- Jul 2018
Total raised
- $6.5M
Investors
- 1
About Cereius
Cereius Inc., founded in 2017 and headquartered in Durham, US, specializes in technology-driven software solutions. The company has completed 4 deals to date, with the most recent deal occurring on June 22, 2023.Cereius is a technology-driven company specializing in innovative software solutions designed to enhance operational efficiency across various industries. Their core product offerings include a suite of enterprise resource planning (ERP) tools that integrate seamlessly with client systems, facilitating real-time data analysis and streamlined workflow management.Cereius generates revenue through a subscription-based model, allowing clients to access their software solutions on a tiered pricing structure. Customers typically engage in annual contracts, with various service tiers available. Following the acquisition by Solve Therapeutics in June 2023, the company anticipates launching innovative features in its ERP offerings to enhance customer satisfaction. Plans include targeting further expansion into Europe and Asia by mid-2024, capitalizing on increasing demand for digitized operational processes in these regions.
Who invested in Cereius
1 investor across 1 round
See all investors in Cereius
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 24, 2018
Amount
$6.5M
Investors
Questions about Cereius
Who invested in Cereius?
Cereius has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cereius raised?
Cereius has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cereius last raise money?
Cereius's most recent round on record is a Series A, in Jul 2018.
What does Cereius do?
Cereius is a biotechnology company.
Where is Cereius headquartered?
Cereius is headquartered in Durham, US.
Which VCs invest in companies like Cereius?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cereius's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Cereius? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.